Next |
home / stock / drma / drma message board
Subject | By | Source | When |
---|---|---|---|
Well it did it | Triple nickle | investorshub | 05/12/2023 1:17:38 PM |
Gotta get thru 3.30 | Triple nickle | investorshub | 05/12/2023 10:20:40 AM |
Dermata Therapeutics Provides Corporate Update and Reports First | subslover | investorshub | 05/12/2023 10:13:57 AM |
great news | Invest-in-America | investorshub | 05/11/2023 10:23:41 PM |
MomentumIts gaining | subslover | investorshub | 05/11/2023 6:07:34 PM |
Nice ride next | Triple nickle | investorshub | 05/11/2023 5:21:19 PM |
Yeah baby | Triple nickle | investorshub | 05/11/2023 5:10:37 PM |
Added fingers crossed | Triple nickle | investorshub | 05/11/2023 4:59:44 PM |
got some short data | subslover | investorshub | 05/11/2023 1:15:05 PM |
great article | Anite | investorshub | 05/04/2023 8:58:23 AM |
Good news recently, we should start to see this one move | Awl416 | investorshub | 05/03/2023 11:17:03 PM |
$DRMA Price trading last trade up | TheFinalCD | investorshub | 05/02/2023 10:55:02 AM |
$DRMA where is the squeeze? | subslover | investorshub | 04/30/2023 10:12:38 PM |
When is this gonna take off? | duderaja | investorshub | 04/30/2023 4:50:26 AM |
$DRMA The trading last trade up | subslover | investorshub | 04/30/2023 12:50:57 AM |
$DRMA Price trading | makinezmoney | investorshub | 04/29/2023 4:40:41 PM |
$DRMA The now | Awl416 | investorshub | 04/24/2023 3:24:14 PM |
bulls and bears | reena969 | investorshub | 04/24/2023 12:46:30 PM |
$DRMA Price now up | Awl416 | investorshub | 04/23/2023 5:58:14 AM |
$DRMA Price gaining | Awl416 | investorshub | 04/22/2023 7:48:52 AM |
News, Short Squeeze, Breakout and More Instantly...
Dermata Therapeutics Inc. Company Name:
DRMA Stock Symbol:
NASDAQ Market:
SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the entry into definitive agreement...
- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial enrollment remains on track - - Dermata continues discussions with potential botulinum toxin partners for DMT410 - - Received issuance of Japanese patent for DMT410 for the treatment of hyperhidrosis - SAN...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...